Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Lab Gains CLIA Certification

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Metabolomics and biochemical analysis developer Metabolon has received Clinical Laboratory Improvement Amendment (CLIA) certification for its new facility in Research Triangle Park, NC.

The company said today that the CLIA certification from the Centers for Medicare and Medicaid Services will enable it to perform high-complexity tests on patient samples.

Metabolon said that later this year it plans to launch tests for insulin resistance and urological cancers based on biochemical markers.

The firm said its profiling technology identifies and measures all of the biochemicals in a biological sample in order to provide information about disease etiology, drug action, and other personalized medicine-related data.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.